Cargando…
An Observational Study to Evaluate the Effectiveness of Rivaroxaban in the Management of Cerebral Venous Sinus Thrombosis
Background and objectives Cerebral venous sinus thrombosis (CVST) is a relatively rare and underdiagnosed type of stroke. Rivaroxaban is licensed for venous thromboembolism in patients opting for elective knee and hip replacement surgeries, preventing pulmonary embolism and precluding stroke and sys...
Autores principales: | Fatima, Meraj, Asghar, Muhammad Sohaib, Abbas, Saira, Iltaf, Samar, Ali, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017467/ https://www.ncbi.nlm.nih.gov/pubmed/33824814 http://dx.doi.org/10.7759/cureus.13663 |
Ejemplares similares
-
Role of Decompressive Craniectomy in the Management of Cerebral Venous Sinus Thrombosis
por: Avanali, Raghunath, et al.
Publicado: (2019) -
Cerebral Venous Sinus Thrombosis in COVID-19: An Unusual Presentation
por: Kaur, Ikwinder, et al.
Publicado: (2021) -
Use of oral rivaroxaban in cerebral venous thrombosis
por: Maqsood, Muhammad, et al.
Publicado: (2020) -
Thyroid Diseases Are an Underestimated Risk Factor for Cerebral Venous Sinus Thrombosis
por: Hieber, Maren, et al.
Publicado: (2020) -
Intrasinus Thrombolysis for Cerebral Venous Sinus Thrombosis: Single-Center Experience
por: Guo, Xinbin, et al.
Publicado: (2019)